| Primary |
| Hypertension |
60.0% |
| Sepsis |
20.0% |
| Supraventricular Tachycardia |
20.0% |
|
| Sinus Bradycardia |
28.6% |
| Hypertension |
14.3% |
| Medication Error |
14.3% |
| Palpitations |
14.3% |
| Product Substitution Issue |
14.3% |
| Tachycardia |
14.3% |
|
| Secondary |
| Product Used For Unknown Indication |
45.2% |
| Hypertension |
38.7% |
| Hypercholesterolaemia |
9.7% |
| Hiv Infection |
6.5% |
|
| Depressed Level Of Consciousness |
33.3% |
| Hypotension |
33.3% |
| Medication Error |
16.7% |
| Rhabdomyolysis |
16.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
29.5% |
| Drug Use For Unknown Indication |
12.9% |
| Hypertension |
12.3% |
| Atrial Fibrillation |
6.7% |
| Pain |
4.2% |
| Rheumatoid Arthritis |
3.8% |
| Diabetes Mellitus |
3.7% |
| Depression |
2.6% |
| Chronic Obstructive Pulmonary Disease |
2.4% |
| Crohn's Disease |
2.4% |
| Gastrooesophageal Reflux Disease |
2.4% |
| Non-small Cell Lung Cancer |
2.4% |
| Prophylaxis |
2.2% |
| Cardiac Disorder |
2.1% |
| Osteoporosis |
2.1% |
| Anxiety |
1.9% |
| Asthma |
1.9% |
| Pulmonary Arterial Hypertension |
1.6% |
| Blood Cholesterol Increased |
1.5% |
| Insomnia |
1.5% |
|
| Vomiting |
13.7% |
| Death |
8.4% |
| Gastrointestinal Haemorrhage |
6.3% |
| Pyrexia |
6.3% |
| Renal Failure Acute |
6.3% |
| Suicidal Ideation |
5.3% |
| Chest Pain |
4.2% |
| Dehydration |
4.2% |
| Drug Ineffective |
4.2% |
| Lower Gastrointestinal Haemorrhage |
4.2% |
| Nausea |
4.2% |
| Product Quality Issue |
4.2% |
| Rectal Haemorrhage |
4.2% |
| Sepsis |
4.2% |
| Urinary Tract Infection |
4.2% |
| Alopecia |
3.2% |
| Anaemia |
3.2% |
| Application Site Rash |
3.2% |
| Asthma |
3.2% |
| Cardiogenic Shock |
3.2% |
|
| Interacting |
| Dyslipidaemia |
57.1% |
| Atrial Fibrillation |
14.3% |
| Cerebrovascular Accident Prophylaxis |
14.3% |
| Product Used For Unknown Indication |
14.3% |
|
| Vomiting |
33.3% |
| Weight Decreased |
33.3% |
| White Blood Cell Count Decreased |
33.3% |
|
